Co-infection with respiratory pathogens among COVID-2019 cases
Xiaojuan Zhu(Liaoning Normal University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Bin Wu(Union Hospital), Yin Chen(Zhejiang Ocean University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Baoli Zhu(Nanjing Medical University), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Tao Wu(Southern Medical University Shenzhen Hospital)
Cited by 637
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
Methanotrophs: Multifunctional bacteria with promising applications in environmental bioengineering
|Biochemical Engineering Journal|2010|208